Norges Bank Takes Position in Haleon PLC Sponsored ADR $HLN

Norges Bank purchased a new stake in Haleon PLC Sponsored ADR (NYSE:HLN) during the 4th quarter, HoldingsChannel reports. The fund purchased 16,175,000 shares of the company’s stock, valued at approximately $163,529,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. First Eagle Investment Management LLC raised its position in shares of Haleon by 9.8% in the third quarter. First Eagle Investment Management LLC now owns 3,056,951 shares of the company’s stock valued at $27,421,000 after purchasing an additional 273,044 shares during the period. Cidel Asset Management Inc. bought a new stake in shares of Haleon in the third quarter valued at approximately $4,043,000. Optiver Holding B.V. bought a new stake in shares of Haleon in the third quarter valued at approximately $45,593,000. JPMorgan Chase & Co. raised its position in shares of Haleon by 36.6% in the third quarter. JPMorgan Chase & Co. now owns 11,984,672 shares of the company’s stock valued at $107,503,000 after purchasing an additional 3,207,986 shares during the period. Finally, Third View Private Wealth LLC bought a new stake in shares of Haleon in the fourth quarter valued at approximately $3,461,000. Institutional investors own 6.67% of the company’s stock.

Haleon Stock Performance

Haleon stock opened at $8.72 on Thursday. The firm’s 50 day simple moving average is $9.45 and its 200 day simple moving average is $9.94. The company has a current ratio of 0.92, a quick ratio of 0.71 and a debt-to-equity ratio of 0.47. The firm has a market capitalization of $38.61 billion, a PE ratio of 22.35, a price-to-earnings-growth ratio of 1.98 and a beta of 0.13. Haleon PLC Sponsored ADR has a 1-year low of $8.65 and a 1-year high of $11.28.

Haleon (NYSE:HLN) last posted its earnings results on Saturday, February 14th. The company reported $6.32 earnings per share for the quarter. The firm had revenue of $3.65 billion for the quarter. As a group, analysts expect that Haleon PLC Sponsored ADR will post 0.56 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research firms have recently issued reports on HLN. Wall Street Zen raised shares of Haleon from a “hold” rating to a “buy” rating in a research report on Saturday, March 21st. Argus raised shares of Haleon to a “strong-buy” rating in a research report on Tuesday, March 17th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “sell” rating on shares of Haleon in a report on Thursday, April 30th. Two investment analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy”.

Haleon Profile

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over?the?counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self?care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.